lobbying_activities: 509851

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
509851	39bbe7f0-8362-44ae-9f23-e564d7cad40a	MM	ACADEMY OF MANAGED CARE PHARMACY	48793	ACADEMY OF MANAGED CARE PHARMACY	2007	mid_year	PHA	* Prescription Drug User Fee Act (PDUFA) re-authorization Food and Drug Administration reform efforts: expansion of post-market surveillance programs for prescription drugs; post-market risk management; additional monitoring of direct-to-consumer advertisements for prescription drugs; additional agency funding. Adjustments to Medicaid prescription drug reimbursement rates (calculation of average manufacturer price). Legislation relating to "follow-on" biologic pharmaceuticals. Legislation relating to authorized generic prescription drugs. Importation of prescription drugs/counterfeit drugs. Federal regulation of the practice of pharmacy compounding,	HOUSE OF REPRESENTATIVES,SENATE		285000	0	0	2007-08-02T15:04:10-04:00